Openbookopenbook
Equity
Utah Medical Products Inc(UTMD)
USD --+0.00%
Reward37Moderate
Risk14Low
📊75%Data
Strong 29% profit margin
UTMD
+0.0 · +0.00%
USD · NASDAQ
Utah Medical Products Inc | Healthcare
Defensive Anchor
Market Cap:213.40M
ℹ️
Reward Rating
37
Moderate
Bottom 5% (model universe)
75% data coverage
ℹ️
Risk Rating
14
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on UTMD to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Utah Medical Products Inc?

provides medical devices for the healthcare industry worldwide.

UTMD · Verdict

Limited reward · low risk

UTMD stands out on volatility and balance sheet, but watch the growth signal.

Based on 88% data coverage

UTMD · Verdict

What’s working & what to watch

Strengths 3

  • Volatility95/100

    Top decile vs peers

  • Balance sheet93/100

    Current ratio 37.62

  • Cash flow87/100

    29% net margin

Watchouts 1

  • Growth13/100

    Rev -9.7% CAGR · earnings -11.8%

Model-based scoring. For information only — not financial advice.

What is Utah Medical Products Inc?

provides medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 213.40M, and a P/E ratio of 19.1x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue growth is subdued, limiting near-term earnings expansion.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Discount reflects uncertainty around future performance.

OpenBook Logo Analysis

Reward: Moderate (37)

The scoring profile indicates weak reward characteristics across most factors, including profitability and momentum. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap213.40M
P/E Ratio19.1408
Dividend Yield1.84%
52 Week High68.71
52 Week Low50.4543
Last AnnualDecember
IPO Date3/8/1999
IncorporatedUSA
Shares Outstanding3M
No. of Employees155
IndustryMedical Instruments & Supplies
ExchangeNASDAQ
Beta0.346
CurrencyUSD
Websitewww.utahmed.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.